Elliptic Laboratories ASA (OSL:ELABS)
Norway flag Norway · Delayed Price · Currency is NOK
2.480
-0.020 (-0.80%)
Aug 4, 2026, 4:25 PM CET

Elliptic Laboratories ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
126.93102.74133.3469.6352.0663.04
Revenue Growth
-7.84%-22.95%91.50%33.75%-17.41%40.92%
Gross Profit
126.93102.74133.3469.6352.0663.04
Operating Income
-25.19-47.244.71-49.89-42.13-11.14
Net Income
-123.97-139.968.96-38.11-33-11.21
Earnings Per Share
-1.43-1.330.08-0.37-0.31-0.11
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
74.0243.0676.39115.58178.22218.15
Total Debt
14.3813.1119.3525.8612.7117.14
Net Cash (Debt)
59.6429.9557.0489.72165.51201.01
Net Cash Growth
-0.49%-47.49%-36.43%-45.79%-17.66%162.69%
Net Cash Per Share
0.540.280.510.861.592.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.675.99-10.61-45.51-17.34-10.82
Capital Expenditures
-0.03-0.03--0.51--
Free Cash Flow
-23.75.96-10.61-46.02-17.34-10.82
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-19.85%-45.98%3.53%-71.65%-80.92%-17.67%
Pretax Margin
-26.83%-58.43%12.78%-67.50%-75.49%-20.77%
Profit Margin
-97.67%-136.23%6.72%-54.74%-63.38%-17.79%
FCF Margin
-18.67%5.80%-7.95%-66.09%-33.31%-17.17%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--131.00---
Forward PE
-16.9812.5940.3340.09-
P/FCF Ratio
-119.89----
PS Ratio
3.426.968.2725.6644.0845.71